These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 26212494)

  • 1. The Key Regulator for Language and Speech Development, FOXP2, is a Novel Substrate for SUMOylation.
    Meredith LJ; Wang CM; Nascimento L; Liu R; Wang L; Yang WH
    J Cell Biochem; 2016 Feb; 117(2):426-38. PubMed ID: 26212494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The language-related transcription factor FOXP2 is post-translationally modified with small ubiquitin-like modifiers.
    Estruch SB; Graham SA; Deriziotis P; Fisher SE
    Sci Rep; 2016 Feb; 6():20911. PubMed ID: 26867680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SUMOylation of ATF3 alters its transcriptional activity on regulation of TP53 gene.
    Wang CM; Brennan VC; Gutierrez NM; Wang X; Wang L; Yang WH
    J Cell Biochem; 2013 Mar; 114(3):589-98. PubMed ID: 22991139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular networks implicated in speech-related disorders: FOXP2 regulates the SRPX2/uPAR complex.
    Roll P; Vernes SC; Bruneau N; Cillario J; Ponsole-Lenfant M; Massacrier A; Rudolf G; Khalife M; Hirsch E; Fisher SE; Szepetowski P
    Hum Mol Genet; 2010 Dec; 19(24):4848-60. PubMed ID: 20858596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intracellular distribution of a speech/language disorder associated FOXP2 mutant.
    Mizutani A; Matsuzaki A; Momoi MY; Fujita E; Tanabe Y; Momoi T
    Biochem Biophys Res Commun; 2007 Feb; 353(4):869-74. PubMed ID: 17196932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SUMOylation of FOXM1B alters its transcriptional activity on regulation of MiR-200 family and JNK1 in MCF7 human breast cancer cells.
    Wang CM; Liu R; Wang L; Nascimento L; Brennan VC; Yang WH
    Int J Mol Sci; 2014 Jun; 15(6):10233-51. PubMed ID: 24918286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional genetic analysis of mutations implicated in a human speech and language disorder.
    Vernes SC; Nicod J; Elahi FM; Coventry JA; Kenny N; Coupe AM; Bird LE; Davies KE; Fisher SE
    Hum Mol Genet; 2006 Nov; 15(21):3154-67. PubMed ID: 16984964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sumoylation of FOXP2 Regulates Motor Function and Vocal Communication Through Purkinje Cell Development.
    Usui N; Co M; Harper M; Rieger MA; Dougherty JD; Konopka G
    Biol Psychiatry; 2017 Feb; 81(3):220-230. PubMed ID: 27009683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphorylation-facilitated sumoylation of MEF2C negatively regulates its transcriptional activity.
    Kang J; Gocke CB; Yu H
    BMC Biochem; 2006 Feb; 7():5. PubMed ID: 16478538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The medaka FoxP2, a homologue of human language gene FOXP2, has a diverged structure and function.
    Itakura T; Chandra A; Yang Z; Xue X; Wang B; Kimura W; Hikosaka K; Inohaya K; Kudo A; Uezato T; Miura N
    J Biochem; 2008 Mar; 143(3):407-16. PubMed ID: 18079162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human-specific transcriptional regulation of CNS development genes by FOXP2.
    Konopka G; Bomar JM; Winden K; Coppola G; Jonsson ZO; Gao F; Peng S; Preuss TM; Wohlschlegel JA; Geschwind DH
    Nature; 2009 Nov; 462(7270):213-7. PubMed ID: 19907493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pax8 protein stability is controlled by sumoylation.
    de Cristofaro T; Mascia A; Pappalardo A; D'Andrea B; Nitsch L; Zannini M
    J Mol Endocrinol; 2009 Jan; 42(1):35-46. PubMed ID: 18974227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ribosomal protein S3 is stabilized by sumoylation.
    Jang CY; Shin HS; Kim HD; Kim JW; Choi SY; Kim J
    Biochem Biophys Res Commun; 2011 Oct; 414(3):523-7. PubMed ID: 21968017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evolution of SUMO Function and Chain Formation in Insects.
    Ureña E; Pirone L; Chafino S; Pérez C; Sutherland JD; Lang V; Rodriguez MS; Lopitz-Otsoa F; Blanco FJ; Barrio R; Martín D
    Mol Biol Evol; 2016 Feb; 33(2):568-84. PubMed ID: 26538142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Key Evolutionary Mutation Enhances DNA Binding of the FOXP2 Forkhead Domain.
    Morris G; Fanucchi S
    Biochemistry; 2016 Apr; 55(13):1959-67. PubMed ID: 26950495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sumoylation of poly(ADP-ribose) polymerase 1 inhibits its acetylation and restrains transcriptional coactivator function.
    Messner S; Schuermann D; Altmeyer M; Kassner I; Schmidt D; Schär P; Müller S; Hottiger MO
    FASEB J; 2009 Nov; 23(11):3978-89. PubMed ID: 19622798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An extended consensus motif enhances the specificity of substrate modification by SUMO.
    Yang SH; Galanis A; Witty J; Sharrocks AD
    EMBO J; 2006 Nov; 25(21):5083-93. PubMed ID: 17036045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FOXP2 promotes the nuclear translocation of POT1, but FOXP2(R553H), mutation related to speech-language disorder, partially prevents it.
    Tanabe Y; Fujita E; Momoi T
    Biochem Biophys Res Commun; 2011 Jul; 410(3):593-6. PubMed ID: 21684252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modification by SUMOylation Controls Both the Transcriptional Activity and the Stability of Delta-Lactoferrin.
    Escobar-Ramirez A; Vercoutter-Edouart AS; Mortuaire M; Huvent I; Hardivillé S; Hoedt E; Lefebvre T; Pierce A
    PLoS One; 2015; 10(6):e0129965. PubMed ID: 26090800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SUMO-1 modification required for transformation by adenovirus type 5 early region 1B 55-kDa oncoprotein.
    Endter C; Kzhyshkowska J; Stauber R; Dobner T
    Proc Natl Acad Sci U S A; 2001 Sep; 98(20):11312-7. PubMed ID: 11553772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.